Cargando…
Potential Risks Related to Modulating Interleukin-13 and Interleukin-4 Signalling: A Systematic Review
INTRODUCTION: Interleukin-13 and interleukin-4 are type-II cytokines signalling through the shared type II interleukin-4 receptor. As a result of their structural similarity, interleukin-13 and interleukin-4 have overlapping functions in the mediation of type-II-driven diseases and are, therefore, p...
Autores principales: | Braddock, Martin, Hanania, Nicola A., Sharafkhaneh, Amir, Colice, Gene, Carlsson, Mats |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938313/ https://www.ncbi.nlm.nih.gov/pubmed/29411337 http://dx.doi.org/10.1007/s40264-017-0636-9 |
Ejemplares similares
-
Evaluation of Antibody Properties and Clinically Relevant Immunogenicity, Anaphylaxis, and Hypersensitivity Reactions in Two Phase III Trials of Tralokinumab in Severe, Uncontrolled Asthma
por: Carlsson, Mats, et al.
Publicado: (2019) -
Neuroimmunology of the Interleukins 13 and 4
por: Mori, Simone, et al.
Publicado: (2016) -
Interleukin-25 Mediated Induction of Angiogenin-4 Is Interleukin-13 Dependent
por: Noor, Zannatun, et al.
Publicado: (2016) -
Current Evidence of Interleukin-6 Signaling Inhibitors in Patients With COVID-19: A Systematic Review and Meta-Analysis
por: Han, Qi, et al.
Publicado: (2020) -
Role of the circulatory interleukin-6 in the pathogenesis of gliomas: A systematic review
por: Singh, Manish, et al.
Publicado: (2022)